Literature DB >> 34937955

Outcome weighted ψ-learning for individualized treatment rules.

Mingyang Liu1, Xiaotong Shen1, Wei Pan2.   

Abstract

An individualized treatment rule is often employed to maximize a certain patient-specific clinical outcome based on his/her clinical or genomic characteristics as well as heterogeneous response to treatments. Although developing such a rule is conceptually important to personalized medicine, existing methods such as the partial least squares Qian and Murphy (2011) suffers from the difficulty of indirect maximization of a patient's clinical outcome, while the outcome weighted learning Y. Zhao, Zeng, Rush, and Kosorok (2012) is not robust against any perturbation of the outcome. In this article, we propose a weighted ψ-learning method to optimize an individualized treatment rule, which is robust against any data perturbation near the decision boundary by seeking the maximum separation. To solve nonconvex minimization, we employ a difference convex algorithm to relax the non-convex minimization iteratively based on a decomposition of the cost function into a difference of two convex functions. On this ground, we also introduce a variable selection method for further removing redundant variables for a higher performance. Finally, we illustrate the proposed method by simulations and a lung health study and demonstrate that it yields higher performances in terms of accuracy of prediction of individualized treatment.

Entities:  

Keywords:  Lung cancer treatments; Personalized medicine; Regularization; Variable selection

Year:  2020        PMID: 34937955      PMCID: PMC8691757          DOI: 10.1002/sta4.343

Source DB:  PubMed          Journal:  Stat        ISSN: 0038-9986


  18 in total

1.  Likelihood-based selection and sharp parameter estimation.

Authors:  Xiaotong Shen; Wei Pan; Yunzhang Zhu
Journal:  J Am Stat Assoc       Date:  2012-06-11       Impact factor: 5.033

2.  On constrained and regularized high-dimensional regression.

Authors:  Xiaotong Shen; Wei Pan; Yunzhang Zhu; Hui Zhou
Journal:  Ann Inst Stat Math       Date:  2013-10       Impact factor: 1.267

3.  Residual Weighted Learning for Estimating Individualized Treatment Rules.

Authors:  Xin Zhou; Nicole Mayer-Hamblett; Umer Khan; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

4.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

5.  Variable Selection for Qualitative Interactions.

Authors:  L Gunter; J Zhu; S A Murphy
Journal:  Stat Methodol       Date:  2011-01-30

6.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

Authors:  P D Scanlon; J E Connett; L A Waller; M D Altose; W C Bailey; A S Buist; D P Tashkin
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

7.  Spirometry in the Lung Health Study. 1. Methods and quality control.

Authors:  P L Enright; L R Johnson; J E Connett; H Voelker; A S Buist
Journal:  Am Rev Respir Dis       Date:  1991-06

8.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

9.  Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Authors:  Rafael G Amado; Michael Wolf; Marc Peeters; Eric Van Cutsem; Salvatore Siena; Daniel J Freeman; Todd Juan; Robert Sikorski; Sid Suggs; Robert Radinsky; Scott D Patterson; David D Chang
Journal:  J Clin Oncol       Date:  2008-03-03       Impact factor: 44.544

10.  Estimation and evaluation of linear individualized treatment rules to guarantee performance.

Authors:  Xin Qiu; Donglin Zeng; Yuanjia Wang
Journal:  Biometrics       Date:  2017-09-28       Impact factor: 2.571

View more
  1 in total

1.  Deep reinforcement learning for personalized treatment recommendation.

Authors:  Mingyang Liu; Xiaotong Shen; Wei Pan
Journal:  Stat Med       Date:  2022-06-18       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.